Document Detail

Extension Study of Participants from the Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis.
MedLine Citation:
PMID:  25179849     Owner:  NLM     Status:  Publisher    
OBJECTIVE: To follow children with juvenile idiopathic arthritis (JIA) who had completed at least 6 months of the TRial of Early Aggressive Therapy (TREAT) clinical study for an additional 2 years, describing safety of early aggressive treatment, disease activity, function, and duration of clinical inactive disease (CID) during followup.
METHODS: Children were treated as per provider's discretion. Physician, patient/parent, and laboratory measures of disease status as well as safety information were collected at clinic visits every 3 months for up to 2 years.
RESULTS: Forty-eight children were followed for a mean of 28 months (range 12-42) beyond the end of the TREAT study. Half of patients were in CID for > 50% of their followup time. Overall, 88% of patients achieved CID at > 1 study visit and 54% achieved clinical remission while taking medication. Six patients were in CID for the duration of the study, and, of those, 2 achieved a full year of clinical remission while not taking medication. Active disease was mild: mean physician's global assessment 2.4, active joint count 3.5, parent global evaluation 2.4, Childhood Health Assessment Questionnaire 0.32, erythrocyte sedimentation rate 19 mm/h, and morning stiffness 23 min. There were no serious adverse events or adverse events reported at grade 3 or higher of Common Terminology Criteria for Adverse Events.
CONCLUSION: Early aggressive therapy in this cohort of patients with polyarticular JIA who had high initial disease activity was associated with prolonged periods of CID in the majority of patients during followup. Those not in CID had low levels of disease activity.
Carol A Wallace; Sarah Ringold; John Bohnsack; Steven J Spalding; Hermine I Brunner; Diana Milojevic; Laura E Schanberg; Gloria C Higgins; Kathleen M O'Neil; Beth S Gottlieb; Joyce Hsu; Marilynn G Punaro; Yukiko Kimura; Audrey Hendrickson
Related Documents :
21952409 - Reshaping of vertebrae during treatment with neridronate or pamidronate in children wit...
25320729 - Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis b p...
10552979 - Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, cl...
25158109 - Efficacy and safety of nebulised amphotericin b (nab) in severe asthma with fungal sens...
22168789 - The efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis b: a mu...
15365399 - The effect of helicobacter pylori eradication on gastroesophageal reflux disease.
6869759 - Etomidate infusion. its use in anaesthesia for general surgery.
23699589 - The clinical usefulness of biphasic cuirass ventilation in the prevention of hypoventil...
24378269 - Band ligation vs. n-butyl-2-cyanoacrylate injection in acute gastric variceal bleeding:...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-9-1
Journal Detail:
Title:  The Journal of rheumatology     Volume:  -     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Urate Transporters: Transforming the Face of Hyperuricemia and Gout.
Next Document:  Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-? Inhibitors...